To support potential label expansion to treat DMD, Capricor plans to provide clinical data on skeletal muscle myopathy by combining Cohorts ... Capricor signed a binding term sheet with Nippon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback